Is HRT Safe? What the Latest Research Says in 2026

Key takeaways

• For most healthy women under 60 or within 10 years of menopause, the benefits of HRT generally outweigh the risks.
• In November 2025, the FDA began removing boxed-warning language on heart disease, breast cancer, and dementia, but risk information remains on labels.
• Risk depends on type, route, dose, timing, and personal history, and patches appear to carry lower clot and stroke risk than tablets.
• HRT isn't associated with weight gain, though it isn't a weight loss treatment.
• Some people shouldn't take HRT, including those with a history of breast cancer, blood clots, or stroke.

If you've tried to figure out whether hormone replacement therapy (HRT) is safe, you've probably hit a wall of mixed messages. Since one big study made headlines in 2002, women have heard that HRT causes cancer, that it's fine, and everything in between. Many got conflicting advice from different clinicians, or no clear advice at all.

So, is HRT safe? For most healthy women in early menopause, the research says the benefits generally outweigh the risks. That answer comes with real caveats, and they matter.

The fear around HRT outlived the science behind it. This guide covers what the FDA changed in 2025, the risks in actual numbers, and how the type of HRT shifts the picture. It also covers who isn't a good candidate, age and duration, and the question of weight.

The short answer: is HRT safe?

For most healthy women with menopause symptoms, the benefits of HRT generally outweigh the risks. That holds when it's started before age 60 or within 10 years of the final period.

That's the position of The Menopause Society. Its guidance says HRT should be considered for women in that window who don't have contraindications (health conditions that make a treatment risky).

That timing window sits at the center of the answer. Outside it, or with certain health histories, the pros and cons of HRT can look very different.

Several factors change the answer for each person:

• Whether it's estrogen alone or combined with a progestogen
• Whether it's taken as a tablet, patch, gel, spray, or vaginal product
• Whether the dose is low or standard
• Whether the person still has a uterus
• Whether there's a personal history of cancer, blood clots, stroke, heart disease, or liver disease

The upside is real. According to The Menopause Society, HRT has been shown to be the most effective treatment for bothersome hot flashes. The society's 2023 position statement says hot flashes affect up to 80% of women in menopause and last seven to nine years on average.

Why HRT got a bad reputation

In 2002, the Women's Health Initiative (WHI), a large US study, stopped one of its HRT trials early. The trial tested estrogen plus a progestin and ended after an average of 5.2 years. According to the results published in JAMA, invasive breast cancer had crossed a preset safety limit, and overall risks outweighed benefits.

Those headlines were frightening, and the fear stuck around for years. A closer look shows why the results didn't apply to everyone:

• The trial's 16,608 participants were aged 50–79, according to JAMA, and the FDA notes the average participant was 63.
• The average age of menopause in the US is 51, the FDA says, so many participants were years past it.
• Everyone took one regimen: conjugated equine estrogens plus medroxyprogesterone acetate, a synthetic progestin.

In absolute terms, JAMA reported about eight more invasive breast cancers per 10,000 women per year on that regimen. Per 10,000 women per year, the trial also found seven more heart disease events, eight more strokes, and eight more pulmonary embolisms (lung clots).

HRT use plummeted in the early 2000s, the FDA says. Since then, guidance from groups like The Menopause Society has focused on age and timing.

Results from one regimen in an older group don't map neatly onto a 51-year-old starting treatment for hot flashes. Many women starting HRT today use different hormones, doses, and routes.

What the FDA changed in 2025

On Nov. 10, 2025, the FDA announced changes to menopausal hormone therapy labels. It began removing boxed-warning language about cardiovascular disease, breast cancer, and probable dementia. A boxed warning is the FDA's most serious label alert, printed inside a black border.

Here's what the change does and doesn't cover:

• The boxed warning for endometrial cancer stays on systemic estrogen-alone products, meaning estrogen that circulates through the whole body.
• Information about heart disease and breast cancer risks remains in the body of the label.
• The probable dementia warning was removed from the full label.
• Labels now add the option of starting HRT for moderate-to-severe hot flashes in women under 60 or within 10 years of menopause.

The rollout is gradual. As of Feb. 12, 2026, the FDA had approved updated labels for the first six products, and 29 companies had submitted changes.

So is hormone replacement therapy safe now that the warning is smaller? The FDA hasn't said HRT is safe for everyone. Risk information is still on the label, and personal history still shapes the answer.

HRT benefits: what it can do

The FDA has approved hormone therapies for moderate-to-severe hot flashes, vaginal dryness and discomfort, and preventing bone loss. Here's what those benefits of HRT can look like in daily life.

Hot flashes and night sweats are the main reason most people consider HRT, and relief is its biggest strength. For some women, fewer night sweats may mean better sleep. Better sleep can make other healthy habits, like regular movement and planned meals, feel more doable.

The need is common. In one 2021 survey cited by the FDA, about 34% of women aged 45–65 reported moderate-to-severe hot flashes.

Estrogen also helps protect bone. The Menopause Society says standard-dose HRT helps prevent bone fractures later in life. Systemic HRT is approved to prevent bone loss, which is different from treating osteoporosis (a disease that makes bones fragile) once it's there.

Low-dose vaginal estrogen treats dryness and discomfort right where they happen. Very little of it enters the bloodstream, so its risks are far lower than those of systemic HRT, according to The Menopause Society.

There are limits, too. Current guidance doesn't support using HRT to prevent heart disease or dementia. Its established role is symptom relief and bone protection.

HRT risks and side effects

Every medication has trade-offs, and HRT is no exception. Here's an honest look at the disadvantages of HRT, in real numbers where they exist.

Breast cancer

Combined HRT (estrogen plus a progestogen) is linked to a small increase in breast cancer risk, and that risk appears to grow with longer use. The UK's National Health Service (NHS) puts it this way: around five extra cases of breast cancer for every 1,000 women who take combined HRT for five years. That's a UK estimate framed differently from the US WHI numbers, so the two aren't directly comparable.

Estrogen-alone HRT, used by people without a uterus, looks different. The American Cancer Society says that with shorter use, it hasn't been linked to higher breast cancer risk and may even slightly lower it. Some long-term studies suggest a higher risk after more than 10 years of use.

Blood clots and stroke

Estrogen taken by mouth raises the risk of venous thromboembolism (VTE), a blood clot in a vein that can travel to the lungs. Patches, gels, and sprays are called transdermal estrogen because they work through the skin. They appear to carry lower clot and stroke risk, and The Menopause Society says transdermal routes and lower doses may decrease that risk.

Endometrial (uterine) cancer

Estrogen on its own can make the endometrium, the lining of the uterus, grow too thick, according to the American Cancer Society. That raises the risk of endometrial cancer. People who still have a uterus take a progestogen (progesterone or a synthetic version called a progestin) with systemic estrogen to protect that lining.

It's also why the FDA kept the endometrial cancer boxed warning on systemic estrogen-alone products.

Common side effects

Day-to-day HRT side effects tend to be milder. They can include:

• Breast tenderness
• Bloating
• Headaches
• Spotting or light bleeding

These often settle within the first few months. If they don't, a clinician may adjust the dose or type.

Does the type of HRT change the risk?

Yes, and it's one of the most useful things to understand before talking with a clinician.

Patches and gels vs. tablets

Transdermal estrogen appears to carry lower clot and stroke risk than tablets, which is one of the main pros of HRT patches.

The Menopause Society and the American College of Obstetricians and Gynecologists (ACOG) both say it may lower that risk. NHS guidance in the UK states it more firmly. Most of this evidence comes from observational studies, which track people over time instead of randomly assigning treatments.

Estrogen alone vs. combined HRT

Estrogen alone is an option only for people without a uterus. Combined HRT protects the uterine lining but carries the small breast cancer increase described above.

Micronized progesterone vs. synthetic progestins

Micronized progesterone matches the progesterone the body makes. The American Cancer Society says it may be safer for the breast than synthetic progestins like the WHI's. More study is needed.

Vaginal estrogen

Low-dose vaginal estrogen is a separate category from systemic HRT, so its risks are assessed separately.

Bioidentical and compounded hormones

"Bioidentical" describes hormones that match the ones the body makes, and some are FDA approved, including certain estradiol and micronized progesterone products. Custom-compounded versions, mixed by a pharmacy, aren't FDA approved or reviewed for safety, effectiveness, or quality. ACOG says they shouldn't be prescribed routinely when FDA-approved options exist, though it allows narrow exceptions, such as an ingredient allergy.

The Menopause Society says custom-compounded hormones aren't safer or more effective than approved bioidentical hormones. Natural HRT isn't risk free. Any compounded product calls for clinician oversight, a licensed pharmacy, and careful sourcing checks.

Who shouldn't take HRT

In general, The Menopause Society's patient guidance and its 2023 position statement say HRT isn't recommended for people with a history of:

• Breast cancer or another estrogen-sensitive cancer
• Uterine cancer
• Unexplained vaginal bleeding
• Liver disease
• Blood clots or an inherited high risk of them
• Stroke
• Heart attack or other heart disease

Non-hormonal medications exist for people who can't take HRT. The Menopause Society's 2023 position statement names two FDA-approved options for hot flashes. They're low-dose paroxetine mesylate (7.5 mg daily) and fezolinetant (45 mg daily).

Paroxetine can interfere with tamoxifen, a breast cancer medication, so that's worth raising with a clinician. The same statement says some other antidepressants may bring mild to moderate relief. They're used off-label, meaning outside their FDA-approved uses.

Is HRT safe after 60, and how long can you stay on it?

Age matters differently depending on whether someone is starting HRT or continuing it.

For starting, The Menopause Society's benefit guidance applies to women under 60 or within 10 years of menopause. Starting later, or more than 10 years past menopause, may tip the balance toward risk. The American Cancer Society also notes that combined HRT raises breast cancer risk in women over 60.

That doesn't automatically rule HRT out for women over 60. It does make an individual risk assessment more important.

For staying on it, there's no arbitrary stop date. The Menopause Society says there's no "right" time to stop. Instead, the decision gets revisited regularly with a clinician as symptoms, health, and goals change.

The data on long-term use are limited. The society's 2022 position statement notes few randomized trials on extended use. It also says observational studies suggest a potential rare breast cancer risk with longer use.

Symptoms can last a long time, too. The Menopause Society's 2023 statement says hot flashes last more than 10 years for about one-third of women. That's one reason duration questions come up so often.

HRT and weight: what to know

Worried about HRT and weight gain? According to The Menopause Society, HRT isn't associated with weight gain. It also isn't a weight loss treatment, so it won't reverse midlife changes on its own.

Midlife weight shifts are rooted in biology, and willpower has little to do with it. The Menopause Society links weight gain at this stage to both aging and hormone changes. Muscle loss, poorer sleep, and insulin resistance (when cells respond less to insulin, so blood sugar is harder to manage) can add to the picture.

There's also a link with hot flashes. The Menopause Society's 2023 statement says women with obesity are more likely to report frequent, severe hot flashes. It adds that weight loss may be considered to ease them, though evidence is limited.

That's why medication works best as one tool alongside nutrition, movement, sleep, and support. Found has deeper articles on menopause weight and on how HRT and GLP-1 medications may work together.

Questions to ask your clinician

A good HRT conversation gets specific. Bringing a short list to the appointment can make a big topic feel more manageable. These questions can help guide it:

• Does the timing fit, given age and time since the last period?
• How do personal and family health history change the risks?
• Which type and route fit best, and why?
• What starting dose makes sense?
• How long is the plan, and how often will it be reassessed?
• What non-hormonal options are worth considering?
• Which symptoms or changes are worth reporting right away?

FAQs about HRT safety

Can you stay on HRT for life?

There's no built-in expiration date. The FDA's 2025 label changes removed boxed-warning advice to use the lowest dose for the shortest time, so duration is more individual.

What are the potential side effects of estrogen?

Common side effects can include breast tenderness, bloating, headaches, and spotting, which often settle within the first few months. Low-dose vaginal estrogen acts differently because very little of it enters the bloodstream, The Menopause Society says.

Does HRT cause breast cancer?

Combined HRT is linked to a small increase. The American Cancer Society says that added risk returns to average within about three years of stopping.

Are bioidentical hormones safer than regular HRT?

Not automatically. The American Cancer Society says compounded bioidentical hormones should be assumed to carry at least the same risks as any other hormone therapy.

Is HRT safe for women over 60?

For women already on HRT, The Menopause Society's 2022 position statement says it doesn't need to be routinely stopped after 60 or 65. Ongoing use comes with regular reassessment instead of an automatic cut-off.

Support for midlife hormones and metabolism

Curious how midlife hormone shifts are affecting your metabolism and weight? Found-affiliated clinicians look at your metabolic health and build a personalized weight care plan. That plan may include weight care medication alongside nutrition, sleep, and movement guidance.

HRT decisions stay with your ob-gyn or primary care provider.

Get started

This article is for informational purposes and isn't a substitute for medical advice. Talk with a qualified clinician about your health history before starting, changing, or stopping any medication.